ZyVersa Therapeutics Inc (ZVSA) concluded trading on Thursday at a closing price of $0.66, with 5.49 million shares of worth about $3.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.69% during that period and on May 29, 2025 the price saw a gain of about 15.45%. Currently the company’s common shares owned by public are about 4.77M shares, out of which, 4.76M shares are available for trading.
Stock saw a price change of 19.80% in past 5 days and over the past one month there was a price change of -1.72%. Year-to-date (YTD), ZVSA shares are showing a performance of -37.84% which decreased to -84.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.47 but also hit the highest price of $6.30 during that period. The average intraday trading volume for ZyVersa Therapeutics Inc shares is 3.64 million. The stock is currently trading 16.94% above its 20-day simple moving average (SMA20), while that difference is down -0.01% for SMA50 and it goes to -54.26% lower than SMA200.
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) currently have 4.77M outstanding shares and institutions hold larger chunk of about 7.44% of that.
The stock has a current market capitalization of $3.14M and its 3Y-monthly beta is at 0.68. It has posted earnings per share of -$7.78 in the same period. It has Quick Ratio of 0.18 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZVSA, volatility over the week remained 7.54% while standing at 8.15% over the month.
